$1.74-7.0%Nov 13 close
Next earnings: November 18, 2026
Figures through June 30, 2026, from the 10-Q filed August 14, 2026
Company outlook: revenue of about $14M for Fiscal year 2026 — down 41.3% on a year earlier ($23.8M)
ASP Isotopes Inc. is scheduled to report next on November 18, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
ASP Isotopes Inc.’s own guidance, from its results release of August 4, 2026. It is the company’s statement of what it expects, not a forecast of ours.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $5.1M | $1.2M | +327.63% |
| Profit | -$34M | -$75.2M | +54.77% |
| Profit per share | -$0.27 | -$1.03 | +73.79% |
| Free Cash Flow | -$27.4M | -$9.7M | -182.72% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“Engineers have achieved near-on miracles in reducing microchip components to nano-scale structures, but eventually atoms become your limiting factor. Now it is time for the particle physicists to lead the way forward in creating materials that will advance technology, and with our isotopic separation technology we are ready to step up and play our part ,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
ASP Isotopes is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. The Company’s proprietary technologies, the Aerodynamic Separation Process (“ASP technology”) and Quantum Enrichment (“QE technology”), are designed to enable the production of isotopes for a range of industrial and advanced technology applications. ASP Isotopes operates isotope enrichment facilities in Pretoria, South Africa, focused on the enrichment of low atomic mass elements, or light isotopes.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from ASP Isotopes Inc.’s Item 2.02 8-K filed August 4, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
ASP Isotopes Inc. has no earnings call transcript available.